BING, Nan,BRILEY, Linda, Perry,BUDDE, Laura, R.,COX, Charles, J.,SPRAGGS, Colin, F.
申请号：
HUE10810654
公开号：
HUE029098T2
申请日:
2010.08.20
申请国别(地区):
HU
年份:
2017
代理人:
摘要：
Methods are provided of treating a human for cancer comprising administering at least one dose of lapatinib, or a pharmaceutically acceptable salt or composition thereof, to a patient, wherein said patient does not have one or more allelic polymorphisms selected from the group of: HLA-DQA1*0201, HLA-DQB1*0202, and HLA-DRB1*0701. Patients may also be free of genotypes in TNXB； rs12153855 and/or rs17207923.
